ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,246, issued on April 7, was assigned to CuriOralRx LLC (Wilmington, Mass.).
"Formulations for enteric delivery of therapeutic agents" was invented by Indu Javeri (North Andover, Mass.) and Kaliappanadar Nellaiappan (Lexington, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Formulations containing pH-sensitive nanoparticles for the enteric delivery of therapeutic agents are provided. The nanoparticles include a pH-sensitive polymer that protects the therapeutic agent against degradation in the stomach and allows it to be released in the small intestine or colon. The nanoparticle formulation is particularly effective at protecting sensitive biot...